Company or ticker...

Halozyme

Halozyme Therapeutics is a biopharmaceutical company focused on the development and commercialization of oncology therapies and drug delivery technologies.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

HALO

12.2B

7.9

32

58.32%

Key Facts

M. Cap

PS

PE

YTD

12.2B

7.9

32

58.32%

10MA

20MA

50MA

200MA

$HALO